|
|
Article: Incyte Genomics and the University of Cambridge Report New Cause of Severe Insulin Resistance; Findings Have Implications for the Treatment of Type 2 Diabetes.
- Article from:
- Business Wire
- Article date:
- July 15, 2002
CopyrightCOPYRIGHT 2002 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health & Medical Writers
Incyte Genomics, Inc. (Nasdaq:INCY), today reported the publication of a paper on July 15, 2002 in the scientific journal Nature Genetics titled, "Digenic Inheritance of Severe Insulin Resistance in a Human Pedigree." The study findings are the result of an ongoing collaboration between Incyte Genomics and world-renowned researchers at the University of Cambridge Departments of Clinical Biochemistry, Medicine, and Public Health, at Addenbrooke's Hospital in Cambridge, UK.
In studies aimed at elucidating the mechanisms underlying type-2 Diabetes Mellitus, the authors describe the genetic basis for one inherited ...
Related newspaper, magazine, and journal articles:
|
|
Article: Incyte Genomics, Inc.
International Directory of Company Histories;
700+ words
...Incyte Genomics, Inc. 3160 Porter Drive Palo Alto ... and based in Palo Alto, California, Incyte Genomics, Inc. (formerly Incyte Pharmaceuticals ... they encode. Born to Lead: 1991-93 Incyte Genomics, Inc. was incorporated in April 1991 ...
|
|